- Home
- PCT vs CNTA Comparison
PCT vs CNTA Comparison
Compare PCT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCT
- CNTA
- Stock Information
- Founded
- PCT 2015
- CNTA 2020
- Country
- PCT United States
- CNTA United Kingdom
- Employees
- PCT N/A
- CNTA N/A
- Industry
- PCT Environmental Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PCT Utilities
- CNTA Health Care
- Exchange
- PCT Nasdaq
- CNTA Nasdaq
- Market Cap
- PCT 1.1B
- CNTA 1.6B
- IPO Year
- PCT N/A
- CNTA 2021
- Fundamental
- Price
- PCT $13.03
- CNTA $13.17
- Analyst Decision
- PCT Strong Buy
- CNTA Strong Buy
- Analyst Count
- PCT 4
- CNTA 10
- Target Price
- PCT $13.00
- CNTA $28.78
- AVG Volume (30 Days)
- PCT 4.4M
- CNTA 1.2M
- Earning Date
- PCT 08-07-2025
- CNTA 08-12-2025
- Dividend Yield
- PCT N/A
- CNTA N/A
- EPS Growth
- PCT N/A
- CNTA N/A
- EPS
- PCT N/A
- CNTA N/A
- Revenue
- PCT $1,580,000.00
- CNTA $15,000,000.00
- Revenue This Year
- PCT $99.94
- CNTA N/A
- Revenue Next Year
- PCT N/A
- CNTA N/A
- P/E Ratio
- PCT N/A
- CNTA N/A
- Revenue Growth
- PCT N/A
- CNTA 118.88
- 52 Week Low
- PCT $4.50
- CNTA $8.46
- 52 Week High
- PCT $15.58
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- PCT 66.70
- CNTA 53.38
- Support Level
- PCT $12.38
- CNTA $12.74
- Resistance Level
- PCT $14.23
- CNTA $14.27
- Average True Range (ATR)
- PCT 0.83
- CNTA 0.71
- MACD
- PCT -0.00
- CNTA 0.08
- Stochastic Oscillator
- PCT 55.75
- CNTA 56.11
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.